Page last updated: 2024-11-02

pentoxifylline and Dysphagia

pentoxifylline has been researched along with Dysphagia in 2 studies

Research Excerpts

ExcerptRelevanceReference
"The purpose of this study was to assess the impact of pentoxifylline and vitamin E on the incidence and severity of radiotherapy-induced oral mucositis and dysphagia in head and neck cancer patients."9.30Pentoxifylline and vitamin E reduce the severity of radiotherapy-induced oral mucositis and dysphagia in head and neck cancer patients: a randomized, controlled study. ( El Wakeel, L; El-Hamamsy, M; Kelany, M; Saad, AS; Sayed, R, 2019)
"The purpose of this study was to assess the impact of pentoxifylline and vitamin E on the incidence and severity of radiotherapy-induced oral mucositis and dysphagia in head and neck cancer patients."5.30Pentoxifylline and vitamin E reduce the severity of radiotherapy-induced oral mucositis and dysphagia in head and neck cancer patients: a randomized, controlled study. ( El Wakeel, L; El-Hamamsy, M; Kelany, M; Saad, AS; Sayed, R, 2019)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sayed, R1
El Wakeel, L1
Saad, AS1
Kelany, M1
El-Hamamsy, M1
Kalkur, C1
Sattur, AP1
Guttal, KS1
Lakshman, AR1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
The Effect of Alpha Lipoic Acid on the Incidence and Severity of Radiotherapy-Induced Oral Mucositis in Head and Neck Cancer Patients[NCT05023863]Phase 2/Phase 370 participants (Anticipated)Interventional2021-09-01Not yet recruiting
The Impact of Pentoxifylline and Vitamin E on The Incidence and Severity of Radiotherapy- Induced Oral Mucositis and Dysphagia in Patients With Head and Neck Cancer[NCT02397486]Phase 260 participants (Actual)Interventional2015-05-02Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

2 trials available for pentoxifylline and Dysphagia

ArticleYear
Pentoxifylline and vitamin E reduce the severity of radiotherapy-induced oral mucositis and dysphagia in head and neck cancer patients: a randomized, controlled study.
    Medical oncology (Northwood, London, England), 2019, Nov-21, Volume: 37, Issue:1

    Topics: Aged; Antioxidants; Deglutition Disorders; Female; Head and Neck Neoplasms; Humans; Male; Middle Age

2019
Pentoxifylline and vitamin E reduce the severity of radiotherapy-induced oral mucositis and dysphagia in head and neck cancer patients: a randomized, controlled study.
    Medical oncology (Northwood, London, England), 2019, Nov-21, Volume: 37, Issue:1

    Topics: Aged; Antioxidants; Deglutition Disorders; Female; Head and Neck Neoplasms; Humans; Male; Middle Age

2019
Pentoxifylline and vitamin E reduce the severity of radiotherapy-induced oral mucositis and dysphagia in head and neck cancer patients: a randomized, controlled study.
    Medical oncology (Northwood, London, England), 2019, Nov-21, Volume: 37, Issue:1

    Topics: Aged; Antioxidants; Deglutition Disorders; Female; Head and Neck Neoplasms; Humans; Male; Middle Age

2019
Pentoxifylline and vitamin E reduce the severity of radiotherapy-induced oral mucositis and dysphagia in head and neck cancer patients: a randomized, controlled study.
    Medical oncology (Northwood, London, England), 2019, Nov-21, Volume: 37, Issue:1

    Topics: Aged; Antioxidants; Deglutition Disorders; Female; Head and Neck Neoplasms; Humans; Male; Middle Age

2019
"Introducing Modified Dakkak and Bennett Grading System for Indian Food in Oral Submucous Fibrosis": A Dharwad Study.
    Journal of dietary supplements, 2019, Volume: 16, Issue:2

    Topics: Antioxidants; Areca; Deglutition Disorders; Female; Food; Humans; India; Male; Nuts; Oral Submucous

2019